Barclays Maintains Equal-Weight on Amrize, Lowers Price Target to $40

Benzinga · 3d ago
Barclays analyst Adam Seiden maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $55 to $40.